Genetic Technologies Gets Nasdaq Non-compliance Letter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received a letter from Nasdaq saying that the firm's shares do not currently meet the exchange's requirements for minimum stockholders' equity.

The Melbourne, Australia-based firm said that the non-compliance was the result of its reported stockholders' equity as of Dec. 31, 2009 falling below the $10 million threshold as required by Nasdaq's rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.